| # | Drug | Count |
|---|---|---|
| 0 | RIVAROXABAN | 21 |
| 1 | TACROLIMUS | 15 |
| 2 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 14 |
| 3 | TACROLIMUS OINTMENT 0.1% | 14 |
| 4 | MYCOPHENOLATE MOFETIL | 11 |
| 5 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 11 |
| 6 | PREDNISONE | 11 |
| 7 | BASILIXIMAB | 10 |
| 8 | MICAFUNGIN | 10 |
| 9 | MICAFUNGIN SODIUM | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IMIPRAMINE PAMOATE | 1 | 0.0061 |
| 1 | FLUCYTOSINE | 8 | 0.0056 |
| 2 | ASIAN GINSENG | 1 | 0.0024 |
| 3 | CERLIPONASE ALFA | 1 | 0.0019 |
| 4 | IMIPRAMINE HYDROCHLORIDE | 1 | 0.0018 |
| 5 | MICAFUNGIN SODIUM | 10 | 0.0015 |
| 6 | BASILIXIMAB | 10 | 0.0008 |
| 7 | GALSULFASE | 3 | 0.0008 |
| 8 | AMPHOTERICIN B | 8 | 0.0006 |
| 9 | POSACONAZOLE | 9 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Nucleoside Analog Antifungal [EPC] | 8 | 0.0056 |
| 1 | Echinocandin Antifungal [EPC] | 10 | 0.0012 |
| 2 | Lipid-based Polyene Antifungal [EPC] | 8 | 0.0006 |
| 3 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 7 | 0.0003 |
| 4 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 3 | 0.0002 |
| 5 | Polyene Antifungal [EPC] | 8 | 0.0002 |
| 6 | Antimetabolite Immunosuppressant [EPC] | 4 | 0.0002 |
| 7 | Tetracycline-class Antibacterial [EPC] | 1 | 0.0001 |
| 8 | Cephalosporin Antibacterial [EPC] | 1 | 0.0001 |
| 9 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |